PharmaResearch Co. announced that it successfully held the 5th PharmaResearch Global Symposium (PGS) at the Lakai Sandpine Resort on Oct. 28-29. This year’s event attracted about 600 aesthetic and medical professionals from 25 countries across Asia, the Americas, Europe and the Middle East.
The symposium prominently featured key aesthetic products, particularly Rejuran, which utilizes PharmaResearch’s proprietary DOT™ (DNA Optimizing Technology) patented technology.
On the first day, attendees visited the Inland Water Life Resources Center to learn about domestic salmon from the Eastern coast, a primary raw material for PDRN and PN. They also toured the PharmaResearch and PharmaResearch Bio facilities in Gangneung, where they observed the advanced processes involved in product manufacturing.
“It was impressive to see the entire process from Rejuran’s raw materials to product manufacturing and packaging firsthand. This experience truly showcased PharmaResearch’s high technological capability and quality control. I now understand why Rejuran is recognized globally,” a participant commented.
On the second day, with Dr. Michael J. Kim, Dr. Nark Kyoung Rho, and Dr. Steven Liew chairing, medical professionals from the US, Indonesia, Australia, China, Japan, Ukraine, Malaysia, Kazakhstan, Thailand and Singapore shared the latest insights on DOT™PN and Rejuran through lectures.
Additionally, the Rejuran Global Research Team “International Research Committee (IRC)” was officially launched on this day. The IRC, composed of domestic and international medical professionals, plans to conduct global research based on Rejuran and DOT™PN.
“Rejuran has proven consistent efficacy and safety across various skin types. We will enhance the value of Rejuran through diverse clinical studies and contribute to establishing it as a trusted medical device for medical professionals in each country,” Dr. Atchima Suwanchinda, a member of the IRC, stated.
“It is significant that medical professionals from around the world could engage in in-depth discussions on the clinical efficacy and safety of Rejuran through this symposium. Especially with the launch of the IRC, we will activate global research and strive to make Rejuran a globally trusted brand by providing effective solutions tailored to various skin types and conditions,” a PharmaResearch official explained.
Write to Jeong Min Nam at
peux@hankyung.com
